Categories: Budget

Post Budget Reaction 2019: By Roche Diagnostics on Healthcare

New Delhi, February 03, 2019: “The Union Budget 2019 speech this morning clearly spelled out the Central Government’s scale-up in healthcare initiatives over the past few years. This is encouraging as this focus helps augment and strengthen health access across India.

While establishing access through healthcare infrastructures like hospitals and medical colleges is great, focused and planned expenditure on improving participation from the public in preventive healthcare at these hospitals through awareness programmes is important.

With the announcement of ambitious projects like Ayushman Bharat last year, expectations were high for the 2019 Budgetary recommendations on healthcare. Some inclusions on outpatient care and diagnostics would have been great. We would have liked to see in this Budget a roadmap for healthcare development programmes announced last year to be implemented seamlessly across the country.”

Dr Shravan Subramanyam, Managing Director, India and Neighbouring Markets, Roche Diagnostics India

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

10 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

1 day ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

5 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

6 days ago